Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 506.67 percent decrease over earnings of $0.15 per share from the same period last year.